Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9

Kou, XX; Ding, H; Li, L; Chao, HT

Chao, HT (corresponding author), Zhengzhou Univ, Dept Gynaecol, Canc Hosp, Zhengzhou, Peoples R China.

ANALYTICAL CELLULAR PATHOLOGY, 2021; 2021 ():

Abstract

Purpose. Cisplatin is one of the most effective drugs for treating ovarian carcinoma (OC), which is among the most lethal types of carcinoma. However,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索